Search
for
Sort by
Research 871–900 of 1000+
- Possibilities for correcting diffuse alopecia associated with prior coronavirus infection (COVID-19)
- Hair, Nail, and Skin Changes during COVID 19 Era
- 345. Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico
- Hair cortisol concentrations in medical nurses during the COVID-19
- 28665 Cutaneous T-cell lymphoma (CTCL) outcomes during COVID-19
- 26021 Delivering care for the underserved during COVID-19 through real-time teledermatology, a cross-sectional review of patients at a student-run free clinic in Dallas
- Prevalence and Pattern of Skin Manifestations in COVID-19 Patients; A Cross-Sectional Observational Study in Saudi Arabia
- NATURAL ANTIVIRALS FOR THE MANAGEMENT OF SARS-COVID-19: A REVIEW
- Whole plant Adiantum capillus-veneris linn extract as an anti-COVID-19 therapy
- P042 A rare case of constrictive pericarditis with co-existing positive COVID-19: probable autoimmune or immunoglobulin related disease
- Reporte de caso: Presentación clínica e importancia de coinfecciones durante pandemia por COVID-19 en pacientes con neoplasias malignas
- ВЛИЯНИЕ АНДРОГЕННОГО СТАТУСА И АНТИАНДРОГЕННОЙ ТЕРАПИИ НА ТЕЧЕНИЕ COVID-19 У МУЖЧИН
- Impact of comorbidity burden on mortality in patients with COVID-19: a retrospective analysis of the Korean health insurance database
- Recomendaciones Rama de Dermatología Pediátrica, Sociedad Chilena de Pediatría. Pandemia COVID-19
- Literature ReviewThe Gabrin Sign and Role of Androgens in COVID-19 Severity: A Look at 3 Studies
- Use of Finasteride and Spironolactone in Hospitalized COVID-19 Patients and Their Effect on Severity Outcomes
- Is there a link between androgenetic alopecia and COVID-19?
- 5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia (vol 35, pg e243, 2021)
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- A Systematic Review of Persistent Symptoms and Residual Abnormal Functioning following Acute COVID-19: Ongoing Symptomatic Phase vs. Post-COVID-19 Syndrome
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- The use of megavoltage radiation therapy in the treatment of thymomas in rabbits: 19 cases
- Uncertainty, Anxiety and Isolation: Experiencing the COVID-19 Pandemic and Lockdown as a Woman with Polycystic Ovary Syndrome (PCOS)
- Ageing, Sex, Obesity, Smoking and COVID-19—Truths, Myths and Speculations
- Induced pluripotent stem cells: Generation methods and a new perspective in COVID-19 research
- Comparison of patients’ diagnoses in a dermatology outpatient clinic during the COVID‐19 pandemic period and pre‐pandemic period
- The impact of individual lifestyle and status on the acquisition of COVID-19: A case—Control study
- Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- Solanum nigrum L. in COVID-19 and post-COVID complications: a propitious candidate